By Budi Oetomo Narendra 
The groundbreaking research, which leveraged a customized workflow allowing direct observation of protein interactions within intact cells, rather than relying on fragmented samples, marks a significant leap in understanding one of the world’s most persistent and dangerous pathogens. This intricate mapping provides an unprecedented view into the molecular mechanisms influenza A employs to hijack host cellular machinery, offering critical insights that could pave the way for more effective antiviral therapies and vaccines.
The Pervasive Threat of Influenza A
Influenza, commonly known as the flu, is far more than a seasonal nuisance. Globally, it is responsible for an estimated 3 to 5 million cases of severe illness each year, leading to as many as 650,000 deaths. Influenza A viruses, in particular, are notorious for their capacity to cause widespread epidemics and have been the drivers of multiple devastating pandemics throughout history. The most infamous of these remains the 1918 Spanish Flu pandemic, caused by an H1N1 strain of influenza A, which claimed an estimated 50 to 100 million lives worldwide – a stark reminder of the virus’s deadly potential. More recently, the 2009 H1N1 pandemic underscored the continuous threat posed by novel influenza strains.
The global economic burden of influenza is also substantial, encompassing healthcare costs, lost productivity, and the strain on public health systems. The ability of influenza viruses to rapidly mutate, a phenomenon known as antigenic drift and shift, necessitates the annual reformulation of vaccines, presenting an ongoing challenge for public health authorities and vaccine manufacturers. Understanding the intricate dance between the virus and its host cell is paramount to developing durable solutions.
Unveiling Viral Hijacking: A New Scientific Approach
Upon entering a human cell, the influenza A virus initiates a complex process of cellular reprogramming. It releases its RNA genome, which contains the genetic blueprints for a small but potent set of viral proteins. These proteins then fan out across the host cell, systematically redirecting its sophisticated molecular systems. The cell, once a bastion of human biology, is effectively transformed into a viral factory, churning out new virus particles.
For decades, scientists have sought a clearer, more granular view of this viral takeover. Such an understanding is crucial for the development of next-generation flu vaccines that offer broader protection and antiviral drugs that are more potent and less susceptible to resistance. Achieving this goal requires knowing precisely which viral proteins interact with human proteins, the exact locations within the cell where these contacts occur, and the specific mechanisms the virus employs through these interactions to support its own replication.
The new study stands out as the first to map direct contacts between influenza proteins and human proteins on a large scale inside intact infected cells. Previous studies often relied on methods that required cells to be broken apart, a process that can introduce artifacts and obscure the true nature of these delicate interactions. Moreover, the structural detail achieved in this research was so precise that it allowed scientists to computationally model how the interacting proteins might physically fit together, offering a three-dimensional perspective on these crucial molecular handshakes.
"Our work provides a new way to study flu-host interactions in their native context and with structural insight," stated Jan Kosinski, Group Leader at EMBL Hamburg and Centre for Structural Systems Biology (CSSB). He emphasized the study’s potential for future research, adding, "The current results are a snapshot of a moment during infection, and it opens the door to studying flu-host interactions across the entire infection cycle."
Overcoming Traditional Experimental Limitations
Tracking protein-protein interactions during an active viral infection presents immense experimental challenges. Many earlier studies relied on biochemical techniques that necessitated the mechanical or chemical lysis (breaking open) of cells before protein contacts could be measured. This destructive approach, while yielding valuable data, inherently distorts the intracellular environment. Once internal cellular compartments are destroyed, proteins that were spatially separated in the living cell may inadvertently come into contact in the laboratory, leading to false positives. Conversely, weak, temporary, or highly localized interactions – precisely the kind often critical for viral processes – could easily be lost or overlooked. This made it difficult for researchers to definitively determine which connections truly existed and were functionally relevant during the actual infection process.
The breakthrough came through a specialized version of cross-linking mass spectrometry (XL-MS), a well-established technique for mapping protein contacts, specifically tailored for virus-infected cells. This innovation was developed by collaborators Boris Bogdanow and Fan Liu at FMP Berlin. "This is when we learned that our collaborators… had developed a specialized version of cross-linking mass spectrometry (XL-MS), a long-established technique for mapping protein contacts, tailored specifically to virus-infected cells," Kosinski recounted.
This specialized XL-MS method provided the crucial advantage the research team needed. It enabled them to "capture" protein interactions in situ, within the living, intact cellular environment. This capability is vital for identifying interactions that occur only briefly, are highly transient, or are confined to particular regions or organelles of an infected cell.
Bogdanow, now a Junior Research Group Leader at the Institute of Virology, Charité – Universitätsmedizin Berlin, elaborated on the technique’s power: "XL-MS allows us to capture protein-protein interactions directly in infected intact cells, while also providing structural information about how these interactions are happening. This gives us insight into the interface between the virus and the human cell and may, through structural modeling, help identify actionable targets for future pharmaceutical interventions."
Combining Experimental Data With Advanced Computational Modeling: The AlphaFold Advantage
The researchers further amplified the power of their XL-MS results by pairing them with cutting-edge computational structural modeling. This integrated approach allowed them to not only identify which viral and human proteins interact but also to estimate their precise three-dimensional positioning when these connections occur.
To construct these detailed structural models, the team employed a modified version of AlphaFold, the revolutionary protein structure prediction algorithm developed by DeepMind. AlphaFold, recognized for its profound impact on structural biology, can accurately predict the 3D structure of a protein based solely on its amino acid sequence. The modification introduced by the EMBL team was critical: it allowed them to feed their experimental cross-linking data directly into the structural modeling process.
"The key advantage of the modified AlphaFold approach is that it allowed us to feed our experimental cross-linking data directly into the structural modeling," explained Kosinski. "This tells the model which parts of the viral and host proteins are close to each other inside infected cells. This was especially useful for virus-host complexes, which are often difficult to predict reliably." This bespoke integration of experimental evidence with powerful AI prediction significantly enhanced the accuracy and reliability of the resulting interaction maps, particularly for complex viral-host protein assemblies that are otherwise challenging to characterize.
Two Key Strategies: How Influenza Hijacks Human Cells
The detailed findings, published in the prestigious journal Nature Microbiology, illuminated two particularly notable strategies that influenza A appears to employ to seize control of human cells. These discoveries offer specific molecular targets for future intervention.
The first strategy centers on hemagglutinin (HA), a critical protein found on the surface of the influenza virus. Hemagglutinin is the primary protein responsible for the virus’s ability to attach to and enter host cells, acting like a key to unlock the cellular door. The researchers meticulously tracked this protein as it navigated through the cell’s intricate internal transport and processing network. This network comprises a series of specialized compartments, including the endoplasmic reticulum and Golgi apparatus, which are responsible for folding, modifying, and preparing proteins before dispatching them to their final destinations within or outside the cell.
The analysis revealed that several human proteins actively participate in helping to fold and modify hemagglutinin correctly during infection. Crucially, some of these host proteins had previously poorly understood or uncharacterized functions. This finding suggests that influenza A exploits these host factors to ensure its own surface proteins are correctly formed and functional, a vital step for producing new infectious viral particles. Understanding these specific host-virus interactions around hemagglutinin processing could open new avenues for drugs that interfere with this crucial stage of viral maturation.
The second significant discovery involved paraspeckles, small, dynamic, droplet-like compartments located inside the cell nucleus. These fascinating organelles are known to play roles in RNA metabolism and cellular stress responses. The research team found that influenza A infection consistently caused these paraspeckle structures to dissolve.
When the paraspeckles broke apart, they released specific RNA-binding proteins that had been sequestered within them. The virus, ever opportunistic, may then co-opt these newly liberated host proteins to support its own replication and transcription processes within the nucleus.
"What surprised us most was the paraspeckles," commented Iuliia Kotova, former predoctoral fellow at the Kosinski Group at EMBL Hamburg, currently at ETH Zurich and first author of the publication. "Watching these tiny organelles in the nucleus dissolve, consistently across every cell line and every flu strain we tested, told us this isn’t a side effect of infection — it might be a strategy."
The disruption of paraspeckles may offer influenza more than one advantage. Kosinski elaborated on this potential dual benefit: "There may also be a second benefit for the virus: some evidence suggests paraspeckles contribute to cellular stress responses and antiviral gene regulation, so disrupting them could also weaken parts of the cell’s defense response." By dismantling these host structures, the virus not only gains access to essential host factors but also potentially blunts the cell’s innate ability to fight back, creating a more permissive environment for its own proliferation.
A Collaborative Endeavor Across Three Institutions
This ambitious project exemplifies the power of interdisciplinary collaboration, drawing on shared technology and expertise from three leading institutions. The critical cross-linking mass spectrometry work, which forms the experimental backbone of the study, was meticulously carried out at Charité – Universitätsmedizin Berlin. Glycoproteomics analyses, essential for understanding protein modifications, were completed at the state-of-the-art EMBL Proteomics Core Facility.
The complex AlphaFold modeling, which integrated the experimental data with advanced computational predictions, was performed on the powerful EMBL Compute Cluster. Concurrently, high-resolution microscopy imaging, crucial for visualizing cellular structures and validating findings, took place at CSSB’s Advanced Light and Fluorescence Microscopy (ALFM) Facility. This multi-institutional synergy was indispensable for tackling the intricate challenges posed by mapping viral-host interactions at such a detailed level.
A New Paradigm for Studying Potential Pandemic Viruses
The findings from this study extend beyond influenza A, demonstrating a powerful new methodology. By studying molecular contacts inside intact infected cells, researchers can now reveal not only where but also how a virus commandeers human cellular machinery. This type of ‘mapping in context’ is anticipated to be broadly applicable, helping to explain the operational strategies of many other viruses, including those with significant pandemic potential.
"While the exact host factors and mechanisms often differ from virus to virus, we think our overall approach — combining in-cell cross-linking, structural modeling, and targeted cell-biology follow-up to map native virus-host interactions at specific stages of infection — remains broadly applicable," Kosinski affirmed. This suggests a scalable framework for virological research.
Although the study specifically examined a laboratory-adapted strain of influenza A, the researchers are confident that this sophisticated strategy can eventually be employed to investigate viruses of greater pandemic relevance. Bogdanow echoed this sentiment: "Although this study has focused on a lab-adapted strain, this study lays the groundwork to apply the methodology to viruses of potential pandemic relevance, such as H5N1, and for uncovering the interaction networks that support their multiplication in human cells."
This research offers a crucial step forward in global health preparedness. By providing unprecedented detail into the molecular warfare waged between influenza A and human cells, it equips scientists with new tools to identify vulnerable points in the viral life cycle. This knowledge is invaluable for the development of more effective and broad-spectrum antiviral drugs, as well as novel vaccine strategies that could protect against future, potentially catastrophic, influenza pandemics. The ability to peer into the inner workings of infected cells with such clarity heralds a new era in infectious disease research, promising to bolster our defenses against existing and emerging viral threats.
